Fundsmith LLP
MEDP icon

Fundsmith LLP’s Medpace MEDP Stock Holding History

Fundsmith LLP’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.7M Sell
52,372
-10,296
-16% -$4.75M 0.2% 26
2026
Q1 		$30.1M Sell
62,668
-19,899
-24% -$10.2M 0.23% 20
2025
Q4 		$46.4M Sell
82,567
-44,970
-35% -$25.5M 0.27% 34
2025
Q3 		$65.6M Hold
127,537
– – 0.33% 32
2025
Q2 		$40M Hold
127,537
– – 0.17% 36
2025
Q1 		$38.9M Hold
127,537
– – 0.18% 37
2024
Q4 		$42.4M Buy
+127,537
New +$43.3M 0.18% 35

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Fundsmith LLP's MEDP Position: Q2 2026 in Review

Fundsmith LLP reduced its Medpace (MEDP) stake by 16% in Q2 2026, selling an estimated $4.75M and leaving 52,372 shares worth $27.7M. The position accounts for 0.2% of the portfolio, ranked #26.

Fundsmith LLP first reported a position in MEDP in Q4 2024 and has held it in 7 quarters since. The position peaked at $65.6M in Q3 2025. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Fundsmith LLP held 52,372 shares of Medpace worth $27.7M as of Q2 2026.
  • Fundsmith LLP sold 10,296 Medpace shares in Q2 2026, an estimated $4.75M.
  • Medpace made up 0.2% of Fundsmith LLP's portfolio in Q2 2026, its #26 holding.
  • Fundsmith LLP first reported a position in Medpace in Q4 2024 and has held it in 7 quarters since.
  • Fundsmith LLP's Medpace position peaked at $65.6M in Q3 2025.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Fundsmith LLP's 13F filing for Q2 2026, filed 14 Aug 2026.